☆ 4.7 Letter

National Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder

JOURNAL OF AFFECTIVE DISORDERS (2024)

Get Full Text
Add to Collection

Journal

JOURNAL OF AFFECTIVE DISORDERS
Volume 346, Issue -, Pages 221-222

Publisher

ELSEVIER
DOI: 10.1016/j.jad.2023.11.008

Keywords

-

Categories

Clinical Neurology Psychiatry

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.